GENERAL ORTHOPAEDICS
No benefits to Cartipatch compared to mosaicplasty for osteochondral defects in the knee
J Orthop Res. 2016 Apr;34(4):658-6555 patients with knee cartilage injuries were randomized to either undergo autologous chondrocyte implantation (ACI) with the use of the Cartipatch scaffold (solid agarose-alginate) or osteochondral transfer through mosaicplasty with an autograft. The purpose of this study was to compare clinical outcomes between ACI with the Cartipatch scaffold as assessed by subjective International Knee Documentation Committee (IKDC) scores. Findings indicated greater improvement in IKDC scores at 2 years follow-up in favour of mosaicplasty. Additionally, a greater number of adverse events were also reported in the Cartipatch group. It should be noted that the number of patients included in this trial did not meet the predetermined sample size calculation.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
